OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Authors :: Hendrik-Tobias Arkenau
Christian D. Rolfo
Matthew G Krebs
Takashi Seto
Salvatore Siena
F. de Braud
Juergen Wolf
Rafal Dziadziuszko
Edna Chow-Maneval
A. Drilon
Fabrice Barlesi
T. John
Pratik S. Multani
C-C. Lin
Robert C. Doebele
Byoung Chul Cho
D.S.W. Tan
Na Cui
M-J. Ahn
Todd Riehl
Source :: Journal of Thoracic Oncology. 13:S321-S322
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
business.industry
Locally advanced
non-small cell lung cancer (NSCLC)
Entrectinib
ROS1 Fusion Positive
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
medicine
Cancer research
business

Full Text Access

Tools